Life Sciences & Healthcare
Pharmaceutical R&D
Identify molecular interaction laws, binding dynamics, and pharmacokinetic equations directly from experimental assay data.
One of 34 industries across 8 sectors served by CDE — the Causal Dynamics Engine for Science and Engineering.
The Challenge
Why Pharmaceutical R&D teams still struggle to explain what is happening
Pharmaceutical R&D produces binding assays, ADMET profiles, dose-response curves, and pharmacokinetic time-series at enormous scale. Research teams spend months on curve-fitting, statistical analysis, and hypothesis testing to connect molecular features to biological responses, yet fragmented analytical workflows cannot keep pace with modern high-content screening and combinatorial chemistry platforms.
Michaelis-Menten kinetics, Hill equations, and standard compartmental pharmacokinetic models all assume the answer takes a known functional form. When the true dynamics fall outside these templates, researchers either miss the relationship or force-fit an inappropriate model. Confounding variables compound the problem: conventional statistical methods struggle to separate genuine molecular interactions from experimental artifacts, batch effects, and non-causal associations in high-throughput screening campaigns.
The CDE Approach
How CDE closes the explanation gap in pharmaceutical r&d
CDE profiles raw data from binding assays, pharmacokinetic studies, and ADMET profiling, then selects the appropriate discovery mode automatically. It discovers governing equations of drug behavior directly from observations, surfacing relationships that template models miss: non-standard dose-response dynamics, unexpected binding cooperativity, and multi-compartment pharmacokinetics with non-linear clearance. Each result is a typed scientific claim with confidence bounds.
Symbolic mode finds closed-form pharmacokinetic equations for absorption, distribution, metabolism, and excretion. Causal mode separates genuine molecular interactions from confounded associations. Every claim is validated through stability analysis, out-of-distribution testing, and automated negative controls, with full provenance recorded in the Evidence Ledger for regulatory traceability.
Discovery Engine
How CDE applies here
Symbolic discovery produces the closed-form rate laws and binding equations pharmacologists need for mechanistic understanding and regulatory submission. Neuro-Symbolic mode handles high-dimensional assay data common in modern drug discovery, encoding complex molecular features through neural architectures with structure extraction yielding interpretable governing equations. Causal mode adds causal graphs showing how molecular modifications propagate through biological pathways, grounding lead optimization in causal evidence rather than empirical correlation.
Causal Graphs
Discovers directed causal structure from observational data — identifiable causal graphs, regime classifications, and intervention predictions.
Governing Equations
Extracts compact governing laws grounded in the causal structure — interpretable equations your team can read, verify, and compare against known theory.
Intervention Design
Proposes targeted experiments to resolve ambiguous causal edges — maximizing information gain where the causal structure is still uncertain.
Causal Validation
Negative controls, falsification tests, and identifiability analysis applied to every causal claim before promotion to the evidence ledger.
Typed Scientific Claims
What CDE discovers
Every discovery CDE produces is a typed scientific claim — not a black-box prediction, but a governed, reproducible, auditable piece of scientific knowledge with full provenance.
- Binding affinity governing equations
- Pharmacokinetic rate laws (absorption, clearance)
- Dose-response causal graphs
- Drug interaction dynamics
- ADMET property prediction laws
Governed Discovery
Make the finding reviewable
Every discovery CDE produces carries the review context around it: a Truth Dial setting, an evidence entry with replay context, and control results including bootstrap stability, out-of-distribution testing, and feature-shuffle validation.
For pharmaceutical r&d, that means teams can compare runs, justify decisions, and decide whether a finding is ready for internal use, external review, or regulated submission.
Same sector
Related industries
Biotechnology
Discover governing equations for biological systems, from CRISPR editing outcomes to fermentation kinetics, directly from experimental time-series.
ViewClinical Research
Identify causal treatment effects and patient response dynamics from clinical trial data.
ViewGenomics & Proteomics
Discover gene regulatory networks and protein interaction dynamics from high-throughput sequencing and mass spectrometry data.
ViewNeuroscience
Uncover dynamical laws governing neural activity from EEG, fMRI, and electrophysiology recordings.
ViewEpidemiology & Public Health
Model disease transmission dynamics, identify causal risk factors, and discover governing equations of epidemic spread from surveillance data.
ViewGet started
Put CDE on a real pharmaceutical r&d problem
Whether you are exploring pharmaceutical r&d data for the first time or scaling an existing research programme, CDE adapts to your workflow. Bring the dataset, the decision pressure, and the constraints. We will map the right discovery path.